Collaborations & Alliances
Related Searches:
Filter by:
421 - 435 of 1243 results
April 9, 2012
Aims to develop oncology and inflammation therapies
Read More »
April 9, 2012
Will be responsible for development and commercialization
Read More »
April 5, 2012
Agreement includes U.S., PR
Read More »
April 4, 2012
Services aim to overcome solubility/permeability challenges
Read More »
April 4, 2012
XmAb platform delivers another candidate for clinical development
Read More »
April 4, 2012
Phase III program in postmenopausal osteoporosis underway
Read More »
April 3, 2012
Will jointly develop and commercialize five Amgen monoclonal antibodies
Read More »
March 30, 2012
Aims to identify biomarkers for Sanofi compound
Read More »
March 30, 2012
Royalty invests $25 million for development of AML drug
Read More »
March 29, 2012
Asterand unit expands access to BioMAP Platform
Read More »
March 26, 2012
Will develop, supply and distribute alternative dosage form products
Read More »
March 22, 2012
Will develop Crohn's disease drug in U.S. and Europe
Read More »
March 21, 2012
Triggers $8.7 million milestone payment
Read More »
March 20, 2012
Heptares eligible to receive as much as $190 million plus royalties
Read More »
421 - 435 of 1243 results
